3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
2
Marijuana Abuse
2
Recurrence
1
Parasomnias
1
Neoplasms
1
Nausea
1
Marijuana Use
1
Glioblastoma
1
Brain Neoplasms
1
Anxiety Disorders
1
Advanced Malignant Solid Tumor
1
Interventions
Music Therapy
7
Cognitive Behavioral Therapy
6
Surveys and Questionnaires
4
Standard of Care
4
Saline Solution
4
Hypnosis
4
Esketamine
4
Therapeutics
3
Psilocybin
3
Palliative Care
2
Methods
2
Cannabidiol
2
Art Therapy
2
nabiximols
1
Waiting Lists
1
Videotape Recording
1
Transcutaneous Electric Nerve Stimulation
1
Transcranial Direct Current Stimulation
1
Timbre Perception
1
Sertraline
1
Self-Help Groups
1
Selective Serotonin Reuptake Inhibitors
1
Respiration
1
Relaxation Therapy
1
Referral and Consultation
1
Psychotherapy
1
Psychosocial Intervention
1
Psychiatric Rehabilitation
1
Population Groups
1
Pharmaceutical Preparations
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anxiety Disorders
×
nabiximols
×
1 year
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled